Taiwan FDA registration 2e4616f368ceead890c141510962f13e
Reashang thyroglobulin detection panel
TW: 禮亞尚甲狀腺球蛋白檢測試劑組
Taiwan·Risk Class 2·DIASORIN S.P.A.·Registered Apr 06, 2012 – Apr 06, 2022CancelledRegistration details
- Analysis ID
- 2e4616f368ceead890c141510962f13e
- Customs Code
- DHA00602344400
Company information
- Manufacturer
- DIASORIN S.P.A.
- Manufacturer Country
- Italy
- Authorized Representative
- EVERLIGHT BIOTECH(TAIWAN) CO., LTD.
Product details
- Intended Use
- This product uses chemical cold light immunoassay (CLIA) technology to quantitatively determine the content of human thyroglobulin (hTg) in human serum and citric acid and human heparin plasma, and must be used with Liashang analyzer for detection and analysis.
- Product Type (Level 1)
- C Immunology and microbiology
- Product Type (Level 2)
- C.5870 甲狀腺自體抗體免疫試驗系統
- Import Information
- import
Dates and status
- Registration Date
- Apr 06, 2012
- Expiry Date
- Apr 06, 2022
- Cancellation Date
- Apr 12, 2024
Cancellation information
- Status
- Logged out
- Reason
- 許可證已逾有效期
About this record
Access comprehensive regulatory information for Reashang thyroglobulin detection panel in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 2e4616f368ceead890c141510962f13e and manufactured by DIASORIN S.P.A.. The authorized representative in Taiwan is EVERLIGHT BIOTECH(TAIWAN) CO., LTD..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices